Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Atropine[1] Atropine (Atropine sulfate anhydrous)[2] Atropine (Atropine),
Atropine sulfate (Atropine sulfate, ISOPTO ATROPINE, ATROPINE) 💬
[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 2 💬
2Scopolamine, atropine, edaravone and dexmedetomidine[4] Atropine (Atropine sulfate anhydrous),
Dexmedetomidine,
Edaravone,
Scopolamine
[7] Atropine (Atropine),
Scopolamine ,
Dexmedetomidine ,
Dexmedetomidine hydrochloride ,
Edaravone ,
Atropine sulfate (Atropine sulfate, ISOPTO ATROPINE, ATROPINE),
Scopolamine hydrobromide 💬
[8] ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
[16] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Hormone signaling, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2 💬